Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander hoofdstuk

2022 | OriginalPaper | Hoofdstuk

20. Schildklieraandoeningen

Auteur: prof. dr. Romana Netea-Maier

Gepubliceerd in: Gendersensitieve huisartsgeneeskunde

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Schildklieraandoeningen, vooral de schildklierdisfuncties, zijn veelvoorkomend. Daarnaast zijn schildkliernoduli zeer prevalent, vooral bij oudere mensen. Epidemiologisch komen schildklieraandoeningen vaker voor bij vrouwen dan bij mannen, en kennen deze genderspecifieke aspecten. Door de zeldzaamheid van deze ziekten bij mannen zijn deze aspecten echter nog niet goed onderzocht. Hoewel de presentatie niet verschillend is bij mannen en vrouwen, brengen bijzondere fysiologische omstandigheden, zoals zwangerschap, de postpartumperiode en menopauze, uitdagingen met zich mee bij vrouwen. Complicaties van hyperthyreoïdie zoals osteoporose, komen vaker voor bij postmenopauzale vrouwen ten opzichte van de gezonden. Anderzijds vormt het mannelijke geslacht een ongunstige risicofactor voor de patiënten met een schildkliercarcinoom en hebben mannen met een hyperthyreoïdie mogelijk een verhoogd risico op cardiovasculaire sterfte. Rekening houden met deze omstandigheden helpt de zorg voor de patiënten met schildklieraandoeningen te verbeteren, zodat deze beter aansluit bij de individuele karakteristieken van de patiënten.
Literatuur
1.
go back to reference Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol. 1995;43(1):55–68. CrossRef Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol. 1995;43(1):55–68. CrossRef
2.
go back to reference Korelitz JJ, McNally DL, Masters MN, Li SX, Xu Y, Rivkees SA. Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States. Thyroid: Official Journal of the American Thyroid Association. 2013;23(6):758–65. CrossRef Korelitz JJ, McNally DL, Masters MN, Li SX, Xu Y, Rivkees SA. Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States. Thyroid: Official Journal of the American Thyroid Association. 2013;23(6):758–65. CrossRef
3.
go back to reference Bates JN, Kohn TP, Pastuszak AW. Effect of thyroid hormone derangements on sexual function in men and women. Sex Med Rev. 2020;8(2):217–30. CrossRef Bates JN, Kohn TP, Pastuszak AW. Effect of thyroid hormone derangements on sexual function in men and women. Sex Med Rev. 2020;8(2):217–30. CrossRef
4.
go back to reference Biondi B, Bartalena L, Cooper DS, Hegedus L, Laurberg P, Kahaly GJ. The 2015 European thyroid association guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism. Eur Thyroid J. 2015;4(3):149–63. CrossRef Biondi B, Bartalena L, Cooper DS, Hegedus L, Laurberg P, Kahaly GJ. The 2015 European thyroid association guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism. Eur Thyroid J. 2015;4(3):149–63. CrossRef
5.
go back to reference Collet TH, Gussekloo J, Bauer DC, et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med. 2012;172(10):799–809. CrossRef Collet TH, Gussekloo J, Bauer DC, et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med. 2012;172(10):799–809. CrossRef
6.
go back to reference Grimnes G, Emaus N, Joakimsen RM, Figenschau Y, Jorde R. The relationship between serum TSH and bone mineral density in men and postmenopausal women: the Tromso study. Thyroid: Official Journal of the American Thyroid Association. 2008;18(11):1147–55. CrossRef Grimnes G, Emaus N, Joakimsen RM, Figenschau Y, Jorde R. The relationship between serum TSH and bone mineral density in men and postmenopausal women: the Tromso study. Thyroid: Official Journal of the American Thyroid Association. 2008;18(11):1147–55. CrossRef
7.
go back to reference Tauchmanova L, Nuzzo V, Del Puente A, et al. Reduced bone mass detected by bone quantitative ultrasonometry and DEXA in pre- and postmenopausal women with endogenous subclinical hyperthyroidism. Maturitas. 2004;48(3):299–306. CrossRef Tauchmanova L, Nuzzo V, Del Puente A, et al. Reduced bone mass detected by bone quantitative ultrasonometry and DEXA in pre- and postmenopausal women with endogenous subclinical hyperthyroidism. Maturitas. 2004;48(3):299–306. CrossRef
8.
go back to reference Gurlek A, Gedik O. Effect of endogenous subclinical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women. Thyroid: Official Journal of the American Thyroid Association. 1999;9(6):539–43. CrossRef Gurlek A, Gedik O. Effect of endogenous subclinical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women. Thyroid: Official Journal of the American Thyroid Association. 1999;9(6):539–43. CrossRef
9.
go back to reference Ugur-Altun B, Altun A, Arikan E, Guldiken S, Tugrul A. Relationships existing between the serum cytokine levels and bone mineral density in women in the premenopausal period affected by Graves’ disease with subclinical hyperthyroidism. Endocr Res. 2003;29(4):389–98. CrossRef Ugur-Altun B, Altun A, Arikan E, Guldiken S, Tugrul A. Relationships existing between the serum cytokine levels and bone mineral density in women in the premenopausal period affected by Graves’ disease with subclinical hyperthyroidism. Endocr Res. 2003;29(4):389–98. CrossRef
10.
go back to reference Lee JS, Buzkova P, Fink HA, et al. Subclinical thyroid dysfunction and incident hip fracture in older adults. Arch Intern Med. 2010;170(21):1876–83. CrossRef Lee JS, Buzkova P, Fink HA, et al. Subclinical thyroid dysfunction and incident hip fracture in older adults. Arch Intern Med. 2010;170(21):1876–83. CrossRef
11.
go back to reference Wirth CD, Blum MR, da Costa BR, et al. Subclinical thyroid dysfunction and the risk for fractures: a systematic review and meta-analysis. Ann Intern Med. 2014;161(3):189–99. CrossRef Wirth CD, Blum MR, da Costa BR, et al. Subclinical thyroid dysfunction and the risk for fractures: a systematic review and meta-analysis. Ann Intern Med. 2014;161(3):189–99. CrossRef
12.
go back to reference Blum MR, Bauer DC, Collet TH, et al. Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA. 2015;313(20):2055–65. CrossRef Blum MR, Bauer DC, Collet TH, et al. Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA. 2015;313(20):2055–65. CrossRef
13.
go back to reference Stott DJ, Rodondi N, Kearney PM, et al. Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med. 2017;376(26):2534–44. CrossRef Stott DJ, Rodondi N, Kearney PM, et al. Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med. 2017;376(26):2534–44. CrossRef
14.
go back to reference Mooijaart SP, Du Puy RS, Stott DJ, et al. Association between levothyroxine treatment and thyroid-related symptoms among adults aged 80 years and older with subclinical hypothyroidism. JAMA. 2019; (20):1977–86. Mooijaart SP, Du Puy RS, Stott DJ, et al. Association between levothyroxine treatment and thyroid-related symptoms among adults aged 80 years and older with subclinical hypothyroidism. JAMA. 2019; (20):1977–86.
Metagegevens
Titel
Schildklieraandoeningen
Auteur
prof. dr. Romana Netea-Maier
Copyright
2022
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-368-2707-2_20